Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
Katarzyna Sędłak, Karol Rawicz-Pruszyński, Radosław Mlak...
https://pubmed.ncbi.nlm.nih.gov/34404560/Actively Recruiting
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-04-11
250
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating the outcomes of patients with gastric cancer who undergo surgery with curative intent before and after the creation of a Multidisciplinary Tumor Board MTB at Fondazione Policlinico Gemelli. This observational study compares surgical and oncologic results, focusing on whether the MTB has improved the quality of care and patient outcomes by reviewing cases weekly in a team setting. The study covers patients treated from January 2018 to the present, with the MTB established in November 2019. The study groups include patients treated before the MTB was established January 2018 to November 2019 and those treated afterward December 2019 onward. Data collection involves reviewing clinical, pathological, surgical, and oncological information for patients with gastric adenocarcinoma who are surgical candidates with curative intent. The MTBs influence on treatment allocation, timing from diagnosis to treatment, and overall adherence to tumor board recommendations is assessed. Participants medical records will be analyzed for outcomes such as Textbook Outcome TO, Textbook Oncological Outcome TOO, time from diagnosis to first treatment TTT, patient-to-treatment allocation PTA, and tumor board adherence TBA. These measures help evaluate the effectiveness of the MTB in improving patient care. The study collects data retrospectively up to February 2024, aiming to detect improvements in surgical and oncological results over time.
CONDITIONS
Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance
L
Laura Antolino, MD, PhD
C
Cristina Vacca
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead Sponsor
Società Italiana di Chirurgia Oncologica SICO - ESSO affiliated
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From January 2018 to February 2024
Participants who undergo routine care for gastric cancer are observed to assess the impact of the Multidisciplinary Tumor Board on treatment outcomes and performance indicators.
Visits occur as part of routine clinical care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Katarzyna Sędłak, Karol Rawicz-Pruszyński, Radosław Mlak...
https://pubmed.ncbi.nlm.nih.gov/34404560/Katarzyna Sędłak, Karol Rawicz-Pruszyński, Radosław Mlak...
https://pubmed.ncbi.nlm.nih.gov/37555342/M E Charlson, P Pompei, K L Ales...
https://pubmed.ncbi.nlm.nih.gov/3558716/Linda M Pak, Tingsong Yang, Jiping Wang
https://pubmed.ncbi.nlm.nih.gov/30366851/Timothy P Hanna, Will D King, Stephane Thibodeau...
https://pubmed.ncbi.nlm.nih.gov/33148535/L A D Busweiler, M G Schouwenburg, M I van Berge Henegouwen...
https://pubmed.ncbi.nlm.nih.gov/28240357/Tae-Han Kim, Yun-Suhk Suh, Yeon-Ju Huh...
https://pubmed.ncbi.nlm.nih.gov/28597328/Brindha Pillay, Addie C Wootten, Helen Crowe...
https://pubmed.ncbi.nlm.nih.gov/26643552/Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead Sponsor
Società Italiana di Chirurgia Oncologica SICO - ESSO affiliated
Collaborating Sponsor